Carregant...
Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT2) inhibitors cause substantially less weight loss than expected from the energy excreted via glycosuria. Our aim was to analyze this phenomenon quantitatively. RESEARCH DESIGN AND METHODS: Eighty-six patients with type 2 diabetes (HbA(1c) 7.8 ± 0.8% [6...
Guardat en:
| Publicat a: | Diabetes Care |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542276/ https://ncbi.nlm.nih.gov/pubmed/26180105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-0355 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|